News | September 29, 2009

Hologic CEO to Open NASDAQ Stock Market on October 1, 2009

Jack Cumming, Hologic Chairman and CEO.

September 29, 2009 - Hologic Inc., a leading developer, manufacturer of diagnostics, medical imaging systems and surgical products for women, announced that Jack Cumming, Hologic Chairman and CEO, will preside over the NASDAQ opening bell ceremony in New York City on Thursday, October 1, 2009 at 9:30 a.m. (EST) for the fourth consecutive year to honor the National Breast Cancer Awareness Month and to kick off Hologic’s “Promise to Me” campaign.

The initiative is focused on increasing awareness of the importance of breast cancer screening and Hologic’s funding of mammograms for underserved women.

The American Cancer Society estimates more than 240,000 new cases of breast cancer are diagnosed in the U.S. each year, with one of eight women being inflicted with this deadly disease in her lifetime.1 "These statistics are overwhelming and we remain deeply committed to helping women worldwide who are afflicted by this dreadful disease,” said Mr. Cumming. “Breast cancer screening programs and technologies, such as digital mammography, have gone a long way toward decreasing death rates from breast cancer and we will continue to do so not only with our current technology, but with the introduction of new technologies such as our 3D Selenia Dimensions digital tomosynthesis system."2

Hologic is the worldwide leader in digital mammography systems with over 5,000 Selenia systems shipped. Digital mammography has set a new standard for providing the earliest detection of breast cancer and Hologic is proud to be the preferred system of choice around the world.

The focus of the Promise to Me campaign is to empower women to take ownership of their health, starting with scheduling an annual mammogram. Program details will be fully available on October 1, 2009, at www.promisetome.com. Through this initiative, Hologic has committed to support women who are unable to afford mammograms, and the Company has done so through a partnership with Remote Area Medical (RAM), a non-profit, volunteer organization dedicated to bringing healthcare services to underserved populations in remote areas in the U.S. and abroad.

Reference:
1. American Cancer Society, Breast Cancer Facts and Figures: 2007-2008.
2. Hologic’s Selenia Dimensions 3-D digital tomosynthesis system is approved for use in Europe, Canada
and other countries and awaiting FDA approval in the United States.

To view the NASDAQ opening bell ceremony on October 1st, 2009, visit
www.nasdaq.com/reference/marketsite_about.stm beginning at 9:15 a.m. (EST).

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...